188 related articles for article (PubMed ID: 33151434)
1. Latanoprost Loaded in Polymeric Nanocapsules for Effective Topical Treatment of Alopecia.
Oliveira ACS; Oliveira PM; Cunha-Filho M; Gratieri T; Gelfuso GM
AAPS PharmSciTech; 2020 Nov; 21(8):305. PubMed ID: 33151434
[TBL] [Abstract][Full Text] [Related]
2. Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia.
Oliveira PM; Alencar-Silva T; Pires FQ; Cunha-Filho M; Gratieri T; Carvalho JL; Gelfuso GM
Eur J Pharm Biopharm; 2022 Mar; 172():78-88. PubMed ID: 35143972
[TBL] [Abstract][Full Text] [Related]
3. Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia.
Hamishehkar H; Ghanbarzadeh S; Sepehran S; Javadzadeh Y; Adib ZM; Kouhsoltani M
Drug Dev Ind Pharm; 2016; 42(6):846-53. PubMed ID: 26154267
[TBL] [Abstract][Full Text] [Related]
4. Dutasteride nanocapsules for hair follicle targeting: Effect of chitosan-coating and physical stimulus.
Ushirobira CY; Afiune LAF; Pereira MN; Cunha-Filho M; Gelfuso GM; Gratieri T
Int J Biol Macromol; 2020 May; 151():56-61. PubMed ID: 32068053
[TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.
Blume-Peytavi U; Lönnfors S; Hillmann K; Garcia Bartels N
J Am Acad Dermatol; 2012 May; 66(5):794-800. PubMed ID: 21875758
[TBL] [Abstract][Full Text] [Related]
6. A randomized comparative study of the efficacy of topical latanoprost versus topical betamethasone diproprionate lotion in the treatment of localized alopecia areata.
Bhat S; Handa S; De D
Indian J Dermatol Venereol Leprol; 2021; 87(1):42-48. PubMed ID: 33580923
[TBL] [Abstract][Full Text] [Related]
7. Development, Cytotoxicity and Eye Irritation Profile of a New Sunscreen Formulation Based on Benzophenone-3-poly(ε-caprolactone) Nanocapsules.
Barbosa TC; Nascimento LÉD; Bani C; Almeida T; Nery M; Santos RS; Menezes LRO; Zielińska A; Fernandes AR; Cardoso JC; Jäguer A; Jäguer E; Sanchez-Lopez E; Nalone L; Souto EB; Severino P
Toxics; 2019 Sep; 7(4):. PubMed ID: 31546707
[TBL] [Abstract][Full Text] [Related]
8. Sustained ex vivo skin antiseptic activity of chlorhexidine in poly(epsilon-caprolactone) nanocapsule encapsulated form and as a digluconate.
Lboutounne H; Chaulet JF; Ploton C; Falson F; Pirot F
J Control Release; 2002 Aug; 82(2-3):319-34. PubMed ID: 12175746
[TBL] [Abstract][Full Text] [Related]
9. Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A.
Calvo P; Sanchez A; Martinez J; Lopez MI; Calonge M; Pastor JC; Alonso MJ
Pharm Res; 1996 Feb; 13(2):311-5. PubMed ID: 8932455
[TBL] [Abstract][Full Text] [Related]
10. Follicular-targeted delivery of spironolactone provided by polymeric nanoparticles.
Ferreira-Nunes R; Cunha-Filho M; Gratieri T; Gelfuso GM
Colloids Surf B Biointerfaces; 2021 Dec; 208():112101. PubMed ID: 34517218
[TBL] [Abstract][Full Text] [Related]
11. Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects.
Mathes C; Melero A; Conrad P; Vogt T; Rigo L; Selzer D; Prado WA; De Rossi C; Garrigues TM; Hansen S; Guterres SS; Pohlmann AR; Beck RCR; Lehr CM; Schaefer UF
J Control Release; 2016 Feb; 223():207-214. PubMed ID: 26686081
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A-loaded poly(d,l-lactide) nanoparticles: a promising tool for treating alopecia.
Fernandes B; Matamá T; Andreia C Gomes ; Cavaco-Paulo A
Nanomedicine (Lond); 2020 Jun; 15(15):1459-1469. PubMed ID: 32552553
[No Abstract] [Full Text] [Related]
13. Effect of latanoprost on hair growth in the bald scalp of the stump-tailed macacque: a pilot study.
Uno H; Zimbric ML; Albert DM; Stjernschantz J
Acta Derm Venereol; 2002; 82(1):7-12. PubMed ID: 12013211
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Off-Label Topical Treatments for the Management of Androgenetic Alopecia: A Review.
Gupta AK; Mays RR; Versteeg SG; Shear NH; Piguet V; Piraccini BM
Clin Drug Investig; 2019 Mar; 39(3):233-239. PubMed ID: 30652260
[TBL] [Abstract][Full Text] [Related]
15. Iontophoresis-targeted, follicular delivery of minoxidil sulfate for the treatment of alopecia.
Gelfuso GM; Gratieri T; Delgado-Charro MB; Guy RH; Vianna Lopez RF
J Pharm Sci; 2013 May; 102(5):1488-94. PubMed ID: 23450524
[TBL] [Abstract][Full Text] [Related]
16. Screening of formulation variables for the preparation of poly(epsilon-caprolactone) nanocapsules containing the local anesthetic benzocaine.
Moraes CM; de Matos AP; Grillo R; de Melo NF; de Paula E; Dias Filho NL; Rosa AH; Fraceto LF
J Nanosci Nanotechnol; 2011 Mar; 11(3):2450-7. PubMed ID: 21449406
[TBL] [Abstract][Full Text] [Related]
17. Combined effect of polymeric nanocapsules and chitosan hydrogel on the increase of capsaicinoids adhesion to the skin surface.
Contri RV; Katzer T; Ourique AF; da Silva AL; Beck RC; Pohlmann AR; Guterres SS
J Biomed Nanotechnol; 2014 May; 10(5):820-30. PubMed ID: 24734535
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata.
El-Ashmawy AA; El-Maadawy IH; El-Maghraby GM
J Dermatolog Treat; 2018 Feb; 29(1):55-64. PubMed ID: 28521549
[TBL] [Abstract][Full Text] [Related]
19. Design of Finasteride-Loaded Nanoparticles for Potential Treatment of Alopecia.
Roque LV; Dias IS; Cruz N; Rebelo A; Roberto A; Rijo P; Reis CP
Skin Pharmacol Physiol; 2017; 30(4):197-204. PubMed ID: 28689207
[TBL] [Abstract][Full Text] [Related]
20. Phospholipid-polymer hybrid nanoparticle-mediated transfollicular delivery of quercetin: prospective implement for the treatment of androgenic alopecia.
Das L; Kaurav M; Pandey RS
Drug Dev Ind Pharm; 2019 Oct; 45(10):1654-1663. PubMed ID: 31382790
[No Abstract] [Full Text] [Related]
[Next] [New Search]
